SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents
@article{Bruin2010SLV330AC, title={SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents}, author={N.M.W.J. de Bruin and Jos Prickaerts and Jos H. M. Lange and Sven Akkerman and Emile Andriambeloson and Michelle de Haan and J. Wijnen and Marlies Van Drimmelen and Elias Hissink and Liesbeth Heijink and Cornelis Gerrit Kruse}, journal={Neurobiology of Learning and Memory}, year={2010}, volume={93}, pages={522-531} }
Figures and Tables from this paper
37 Citations
Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats
- Biology, MedicineNeurobiology of Learning and Memory
- 2011
The selective 5-HT6 receptor antagonist SLV has putative cognitive- and social interaction enhancing properties in rodent models of cognitive impairment
- Biology, PsychologyNeurobiology of Learning and Memory
- 2016
AM281, Cannabinoid Antagonist/Inverse agonist, Ameliorates Scopolamine-Induced Cognitive Deficit
- Biology, MedicineIranian journal of basic medical sciences
- 2012
AM281 significantly restored object recognition ability in mice treated with scopolamine by 75% and extended earlier findings, suggesting the interaction of cannabinoid and cholinergic system in memory.
SLV330, a cannabinoid CB1 receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats
- Biology, PsychologyBehavioural Brain Research
- 2011
Methyllycaconitine- and scopolamine-induced cognitive dysfunction: differential reversal effect by cognition-enhancing drugs
- Biology, PsychologyPharmacology research & perspectives
- 2014
The results show that MLA elicited cognitive dysfunction as assessed by reduced spontaneous alternation of mice in the T‐maze, indicating that MLA‐induced cognitive dysfunction in the mouse is highly sensitive and more responsive to the current procognitive drugs than the traditional scopolamine‐based assay.
Procognitive effect of AC-3933 in aged mice, and synergistic effect of combination with donepezil in scopolamine-treated mice.
- Biology, PsychologyEuropean journal of pharmacology
- 2014
Novel object recognition memory in REM sleep-deprived rats: Role of the cannabinoid CB1 receptor
- Biology, PsychologyBehavioural Brain Research
- 2020
Cocaine- and Amphetamine-Regulated Transcript Peptide (CART) Alleviates MK-801-Induced Schizophrenic Dementia-Like Symptoms
- Psychology, BiologyNeuroscience
- 2018
Task- and Treatment Length–Dependent Effects of Vortioxetine on Scopolamine-Induced Cognitive Dysfunction and Hippocampal Extracellular Acetylcholine in Rats
- Psychology, BiologyThe Journal of Pharmacology and Experimental Therapeutics
- 2016
Examination of vortioxetine’s ability to reverse scopolamine-induced impairments in rodent tests of memory and attention found that it has some effects on memory that could be mediated through cholinergic neurotransmission, however these effects are modest and only seen under acute dosing conditions.
Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia
- Biology, PsychologyProgress in Neuro-Psychopharmacology and Biological Psychiatry
- 2019
References
SHOWING 1-10 OF 47 REFERENCES
Cannabinoids alter recognition memory in rats.
- Biology, PsychologyPolish journal of pharmacology
- 2003
First evidence that cannabinoids impair recognition memory in rats is found, as a stable analogue of endogenous cannabinoid anandamide and a potent CB(1) receptor agonist, CP 55,940 significantly attenuated recognition memory.
The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze
- Biology, PsychologyNeuroscience Letters
- 2005
SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task.
- Biology, PsychologyEuropean journal of pharmacology
- 2003
Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716
- BiologyPsychopharmacology
- 2005
The results strongly support the concept that blockade of CB1 receptors plays an important role in consolidation of short-term memory in rodents and suggest there may be a role for an endogenous cannabinoid agonist tone (anandaminergic) in forgetting.
SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats.
- Psychology, BiologyEuropean journal of pharmacology
- 2000
The Selective 5-HT6 Receptor Antagonist Ro4368554 Restores Memory Performance in Cholinergic and Serotonergic Models of Memory Deficiency in the Rat
- Biology, PsychologyNeuropsychopharmacology
- 2005
Although Ro4368554 did not improve a time-related retention deficit, it reversed a cholinergic and a serotonergic memory deficit, suggesting that both mechanisms may be involved in the facilitation of object memory by Ro4 368554 and, possibly, other 5-HT6 receptor antagonists.
Cannabinoid CB1 receptor-mediated impairment of visuospatial attention in the rat
- Psychology, BiologyPsychopharmacology
- 2004
It is suggested that CB1Rs mediate the attentional performance impairments caused by acute administration of cannabinoid agonists and begin to unravel the possible contribution of cannabinoid systems to the pathophysiological substrates of cognitive dysfunction in schizophrenia.
Effects of intrahippocampal cannabinoid receptor agonist and antagonist on radial maze and T-maze delayed alternation performance in rats
- Biology, PsychologyPharmacology Biochemistry and Behavior
- 2008
Beneficial effects of galantamine on performance in the object recognition task in Swiss mice: Deficits induced by scopolamine and by prolonging the retention interval
- Biology, PsychologyPharmacology Biochemistry and Behavior
- 2006
Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats
- Biology, PsychologyNeuropharmacology
- 2004